Yves-Stephane Couture
Tracked across 2 events · 12 articles · First seen Jul 27, 2026 · Last active Aug 13, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
On August 13, 2026, Diagnosis Inc., a Canadian company specializing in AI-based early detection of eye diseases, announced that it received Medical Device Marketing Authorization for its CARA System from the Saudi Arabia — Saudi…
Impact: Yves-Stephane Couture, COO, called the authorization a milestone in commercialization efforts. His role is operational.
Aug 13, 2026 · 6 articles
Regulatory
Impact: Yves-Stephane Couture is COO of Diagnosis, expressed excitement about bringing CARA to Canadian optometrists.
Jul 27, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Yves-Stephane Couture live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard